Joel Beatty
Stock Analyst at Baird
(4.62)
# 221
Out of 5,182 analysts
213
Total ratings
52.66%
Success rate
35.74%
Average return
Main Sectors:
Stocks Rated by Joel Beatty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELF e.l.f. Beauty | Maintains: Outperform | $115 → $90 | $63.72 | +41.24% | 10 | Apr 28, 2026 | |
| DNLI Denali Therapeutics | Maintains: Outperform | $32 → $34 | $19.94 | +70.51% | 4 | Apr 7, 2026 | |
| IMMP Immutep | Downgrades: Neutral | $7 → $1 | $0.52 | +90.66% | 6 | Mar 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Outperform | $67 → $132 | $87.16 | +51.45% | 4 | Mar 10, 2026 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $14 → $20 | $13.00 | +53.85% | 4 | Mar 6, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $275 → $433 | $330.99 | +30.82% | 3 | Feb 20, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Outperform | $72 → $47 | $23.99 | +95.91% | 5 | Dec 30, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $160 → $209 | $201.22 | +3.87% | 5 | Nov 18, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Outperform | $10 → $19 | $16.88 | +12.56% | 5 | Oct 16, 2025 | |
| LRMR Larimar Therapeutics | Maintains: Outperform | $10 → $7 | $4.44 | +57.66% | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $6 | $2.89 | +107.61% | 5 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $36.61 | -75.41% | 6 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $31 | $22.30 | +39.01% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $38 → $24 | $27.05 | -11.28% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $680 | $783.74 | -13.24% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $66 | $69.22 | -4.65% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $162 | $187.40 | -13.55% | 5 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $33.73 | +21.55% | 3 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $32 | $29.27 | +9.33% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $90.24 | -16.89% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $65 | $53.81 | +20.81% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $540 → $240 | $0.24 | +100,952.63% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.5 | $1.53 | +194.12% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $25 | $16.49 | +51.61% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $28 | $21.00 | +33.33% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.47 | +988.44% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $1.25 | $1.56 | -19.87% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $44 | $1.21 | +3,536.36% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $58 | $73.60 | -21.20% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $24 | $29.48 | -18.59% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 | $8.30 | +116.87% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $6 | $1.72 | +248.84% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $36 → $28 | $10.64 | +163.16% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $175 | $308.51 | -43.28% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 | $6.79 | +106.19% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $108 | $20.98 | +414.78% | 10 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $78 | $72.23 | +7.99% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $100 | $20.39 | +390.44% | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $120 | $13.93 | +761.45% | 14 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $450 | $4.21 | +10,588.84% | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.91 | - | 12 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $8.07 | +85.87% | 11 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $14 → $11 | $17.65 | -40.51% | 8 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $9.07 | +109.48% | 3 | Nov 10, 2017 |
e.l.f. Beauty
Apr 28, 2026
Maintains: Outperform
Price Target: $115 → $90
Current: $63.72
Upside: +41.24%
Denali Therapeutics
Apr 7, 2026
Maintains: Outperform
Price Target: $32 → $34
Current: $19.94
Upside: +70.51%
Immutep
Mar 13, 2026
Downgrades: Neutral
Price Target: $7 → $1
Current: $0.52
Upside: +90.66%
Dianthus Therapeutics
Mar 10, 2026
Maintains: Outperform
Price Target: $67 → $132
Current: $87.16
Upside: +51.45%
Contineum Therapeutics
Mar 6, 2026
Maintains: Outperform
Price Target: $14 → $20
Current: $13.00
Upside: +53.85%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Outperform
Price Target: $275 → $433
Current: $330.99
Upside: +30.82%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Outperform
Price Target: $72 → $47
Current: $23.99
Upside: +95.91%
Jazz Pharmaceuticals
Nov 18, 2025
Maintains: Outperform
Price Target: $160 → $209
Current: $201.22
Upside: +3.87%
Amylyx Pharmaceuticals
Oct 16, 2025
Maintains: Outperform
Price Target: $10 → $19
Current: $16.88
Upside: +12.56%
Larimar Therapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $4.44
Upside: +57.66%
Aug 13, 2025
Maintains: Outperform
Price Target: $4 → $6
Current: $2.89
Upside: +107.61%
Jul 8, 2025
Maintains: Neutral
Price Target: $7 → $9
Current: $36.61
Upside: -75.41%
May 19, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $22.30
Upside: +39.01%
May 16, 2025
Downgrades: Neutral
Price Target: $38 → $24
Current: $27.05
Upside: -11.28%
May 13, 2025
Upgrades: Outperform
Price Target: $680
Current: $783.74
Upside: -13.24%
May 7, 2025
Maintains: Outperform
Price Target: $70 → $66
Current: $69.22
Upside: -4.65%
May 6, 2025
Maintains: Outperform
Price Target: $160 → $162
Current: $187.40
Upside: -13.55%
May 2, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $33.73
Upside: +21.55%
Mar 3, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $29.27
Upside: +9.33%
Nov 25, 2024
Initiates: Outperform
Price Target: $75
Current: $90.24
Upside: -16.89%
Oct 30, 2024
Maintains: Neutral
Price Target: $72 → $65
Current: $53.81
Upside: +20.81%
May 15, 2024
Maintains: Outperform
Price Target: $540 → $240
Current: $0.24
Upside: +100,952.63%
Apr 30, 2024
Downgrades: Neutral
Price Target: $4.5
Current: $1.53
Upside: +194.12%
Apr 11, 2024
Maintains: Outperform
Price Target: $24 → $25
Current: $16.49
Upside: +51.61%
Oct 3, 2023
Maintains: Outperform
Price Target: $32 → $28
Current: $21.00
Upside: +33.33%
Jun 1, 2023
Initiates: Outperform
Price Target: $16
Current: $1.47
Upside: +988.44%
May 2, 2023
Maintains: Outperform
Price Target: $4 → $1.25
Current: $1.56
Upside: -19.87%
Apr 13, 2023
Initiates: Outperform
Price Target: $44
Current: $1.21
Upside: +3,536.36%
Feb 7, 2023
Maintains: Outperform
Price Target: $60 → $58
Current: $73.60
Upside: -21.20%
Nov 18, 2022
Maintains: Outperform
Price Target: $18 → $24
Current: $29.48
Upside: -18.59%
Nov 10, 2022
Downgrades: Underperform
Price Target: $18
Current: $8.30
Upside: +116.87%
Aug 29, 2022
Maintains: Outperform
Price Target: $9 → $6
Current: $1.72
Upside: +248.84%
Mar 3, 2022
Upgrades: Neutral
Price Target: $36 → $28
Current: $10.64
Upside: +163.16%
Feb 12, 2021
Downgrades: Neutral
Price Target: $170 → $175
Current: $308.51
Upside: -43.28%
Jan 14, 2021
Downgrades: Neutral
Price Target: $14
Current: $6.79
Upside: +106.19%
Jan 12, 2021
Downgrades: Neutral
Price Target: $108
Current: $20.98
Upside: +414.78%
Aug 10, 2020
Maintains: Buy
Price Target: $80 → $78
Current: $72.23
Upside: +7.99%
Apr 6, 2020
Maintains: Buy
Price Target: $140 → $100
Current: $20.39
Upside: +390.44%
Apr 1, 2020
Maintains: Buy
Price Target: $480 → $120
Current: $13.93
Upside: +761.45%
Mar 26, 2020
Maintains: Buy
Price Target: $480 → $450
Current: $4.21
Upside: +10,588.84%
Mar 17, 2020
Upgrades: Buy
Price Target: n/a
Current: $1.91
Upside: -
Sep 24, 2019
Maintains: Buy
Price Target: $19 → $15
Current: $8.07
Upside: +85.87%
Aug 17, 2018
Upgrades: Neutral
Price Target: $14 → $11
Current: $17.65
Upside: -40.51%
Nov 10, 2017
Maintains: Buy
Price Target: $15 → $19
Current: $9.07
Upside: +109.48%